COMPOUNDS WHICH MODULATE THE CB2 RECEPTOR

Compounds of formula (I) are disclosed. Compounds according to the invention bind to and are agonists, antagonists or inverse agonists of the CB2 receptor, and are useful for treating inflammation. Those compounds which are agonists are additionally useful for treating pain.

Saved in:
Bibliographic Details
Main Authors ERMANN MONIKA, JENKINS JAMES EDWARD, BERRY ANGELA, BARTOLOZZI ALESSANDRA, MUSHI INNOCENT, RIETHER DORIS
Format Patent
LanguageEnglish
Published 13.12.2012
Subjects
ACYCLIC OR CARBOCYCLIC COMPOUNDS
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

Abstract Compounds of formula (I) are disclosed. Compounds according to the invention bind to and are agonists, antagonists or inverse agonists of the CB2 receptor, and are useful for treating inflammation. Those compounds which are agonists are additionally useful for treating pain.
AbstractList Compounds of formula (I) are disclosed. Compounds according to the invention bind to and are agonists, antagonists or inverse agonists of the CB2 receptor, and are useful for treating inflammation. Those compounds which are agonists are additionally useful for treating pain.
Author BERRY ANGELA
BARTOLOZZI ALESSANDRA
ERMANN MONIKA
JENKINS JAMES EDWARD
RIETHER DORIS
MUSHI INNOCENT
Author_xml – fullname: ERMANN MONIKA
– fullname: JENKINS JAMES EDWARD
– fullname: BERRY ANGELA
– fullname: BARTOLOZZI ALESSANDRA
– fullname: MUSHI INNOCENT
– fullname: RIETHER DORIS
BookMark eNrjYmDJy89L5WTQdPb3DfAP9XMJVgj38HT2UPD1dwn1cQxxVQjxcFVwdjJSCHJ1dg0I8Q_iYWBNS8wpTuWF0twMym6uIc4euqkF-fGpxQWJyal5qSXxocFGBoZGxoZmhubGjobGxKkCAKC8Jtg
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID US2012316173A1
GroupedDBID EVB
ID FETCH-epo_espacenet_US2012316173A13
IEDL.DBID EVB
IngestDate Fri Jul 19 13:54:09 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_US2012316173A13
Notes Application Number: US201113521246
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20121213&DB=EPODOC&CC=US&NR=2012316173A1
ParticipantIDs epo_espacenet_US2012316173A1
PublicationCentury 2000
PublicationDate 20121213
PublicationDateYYYYMMDD 2012-12-13
PublicationDate_xml – month: 12
  year: 2012
  text: 20121213
  day: 13
PublicationDecade 2010
PublicationYear 2012
RelatedCompanies BERRY ANGELA
BOEHRINGER INGELHEIM INTERNATIONAL GMBH
BARTOLOZZI ALESSANDRA
ERMANN MONIKA
JENKINS JAMES EDWARD
RIETHER DORIS
MUSHI INNOCENT
RelatedCompanies_xml – name: BARTOLOZZI ALESSANDRA
– name: MUSHI INNOCENT
– name: JENKINS JAMES EDWARD
– name: BERRY ANGELA
– name: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
– name: RIETHER DORIS
– name: ERMANN MONIKA
Score 2.8713222
Snippet Compounds of formula (I) are disclosed. Compounds according to the invention bind to and are agonists, antagonists or inverse agonists of the CB2 receptor, and...
SourceID epo
SourceType Open Access Repository
SubjectTerms ACYCLIC OR CARBOCYCLIC COMPOUNDS
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title COMPOUNDS WHICH MODULATE THE CB2 RECEPTOR
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20121213&DB=EPODOC&locale=&CC=US&NR=2012316173A1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1bS8MwFD6MKeqbTsXLlIJS8KHYLuvKHoqsaUoVe6EX3dto1jwMZA5X8e97Ejrd095ygdzgy_m-5OQE4B5Z7twmlWMIh3AD9VdtcLQrmLWFhNNQCHmgH8WjsBy-TO1pBz42b2FUnNAfFRwRETVHvDdqv179H2L5yrdy_cgXWPT5FBSur7fq2BrICGW677ksTfyE6pS6Za7HmaojksuTCWqlPSTSjsQDe_Pku5TVtlEJjmE_xfaWzQl0xLIHh3Tz91oPDqL2yhuTLfrWp_BAkyhNytjPtffwmYZalPjl66RgWhEyjXoDLWOUpUWSncFdwAoaGtjn7G-KszLfHiA5hy6Kf3EBmjMWA5MgzTGR-VgVH9dCVCMuUCjxurLNS-jvaulqd_U1HMmsdM-wSB-6zde3uEEj2_BbtTa_c4J7Cw
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1bS8MwFD6MKc43nYqXqQWl4EOxbdaVPRTZ0pRO1wu96N5Gs-ZBkDlcxb_vSel0T3tLciA3-HK-L5cTgHtkuQuLFLYmbMI11F-lxtGvYNYSEk59IeSGfhAO_Lz_PLNmLfjYvIWp44T-1MEREVELxHtVr9er_00st75buX7k71j0-eRljqs26tgwZYQy1R07LI7ciKqUOnmqhkltI5LLkxFqpT0k2bbEA3sdy3cpq22n4h3Bfoz1LatjaIllFzp08_daFw6C5sgbkw361ifwQKMgjvLQTZU3f0J9JYjcfDrKmJL5TKFjU0kYZXEWJadw57GM-hq2Of8b4jxPtztIzqCN4l-cg2IPhakTpDk6Mh-j4MNSiGLABQolXhaWfgG9XTVd7jbfQsfPgul8OglfruBQmuRVDYP0oF19fYtrdLgVv6nn6RdkGn3-
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=COMPOUNDS+WHICH+MODULATE+THE+CB2+RECEPTOR&rft.inventor=ERMANN+MONIKA&rft.inventor=JENKINS+JAMES+EDWARD&rft.inventor=BERRY+ANGELA&rft.inventor=BARTOLOZZI+ALESSANDRA&rft.inventor=MUSHI+INNOCENT&rft.inventor=RIETHER+DORIS&rft.date=2012-12-13&rft.externalDBID=A1&rft.externalDocID=US2012316173A1